Michels, Monique
Córneo, Emily
Rocha, Luana Bezerra Gonçalves
Dias, Rodrigo
Voytena, Ana Paula Lorenzen
Rossetto, Marina
Ramlov, Fernanda
Dal-Pizzol, Felipe
Jesus, Gabriel Fernandes Alves
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (MONIQUE MICHELS - PDI)
Article History
Received: 26 July 2022
Accepted: 6 March 2023
First Online: 24 March 2023
Declarations
:
: Gabbia Biotechnology are developing paraprobiotics for the commercial purposes. Marina Rosseto, Ana Paula Voytena and Fernanda Ramlov are members of Gabbia Biotechnology. Monique Michels and Gabriel Alves Jesus are members of Biohall Research and Innovation. The authors declared no potential conflicts of interest.